Abterra Bio Has Moved To Sorrento Valley
In 2009, Abterra Bio began as Digital Proteomics LLC, a spin-out of the University of California – San Diego. Founders Pavel Pevzner and Vineet Bafna, as well as Natalie Castellana, Stefano Bonissone, and Anand Patel have been a part of Abterra’s story since its inception.
Our employees fine-tuned the technology for antibody sequencing and discovery, and as we started to hire more people, we outgrew our first location: a shared lab bench in a biotech start-up incubator. In 2020 with 6 employees, we moved to the San Diego Science Center, our first real office and lab that we could call our own. We invested in a Thermo Fisher Orbitrap Eclipse mass spectrometer to expand our throughput and add capabilities to our services to customers looking for antibody discovery, sequencing, and repertoire analysis. Throughout our time there, we continued to grow (See the Abterra team now), and eventually traded that office for yet another larger one.
Our current chapter has begun in our new Sorrento Valley office and we couldn’t be more excited. We’re enjoying our state-of-the-art lab, multiple floors of offices, and even a conference room! At first we wondered, “Is this too much?” but after some reflection, realized how hard we have worked to get here. We’ve already begun filling the lab with new equipment, including a new sequencer that quadruples our NGS sequencing throughput. Our new space provides the room to grow our team and our capabilities for our valued customers.
If you’re considering a project with us, we’d love to talk to you.
Related Posts
VHH Antibody Repertoire to Phage Library Comparison
We used Reptor to compare the VHH antibody repertoire from an immunized llama to a phage library constructed from the same source.
Case Study: Reptor Biological vs Technical Replicates
Replicates of immune repertoire sequencing projects can provide invaluable information about the total diversity of a sample.
Abterra Biosciences is a unique CRO offering antibody sequencing and discovery services. We bring sophisticated algorithmic and machine learning approaches to enable accurate antibody sequencing and functional antibody discovery.
Tell Us About Your Project
Follow Abterra Bio On Social Media
More From Our Blog
Why Sequence My Antibody Protein?
Why should I sequence my antibody protein? Abterra Bio gives the top reasons to sequence your antibody protein.
Case Study: Alicanto Discovers High Affinity Rabbit Antibodies to Detect Neurofibromin
Infixion Bioscience and Abterra Bio set out to develop high affinity neurofibromin antibody reagents to detect NF1.
Customer Spotlight: Dr. Matthew Burchill
Dr. Burchill explains how Valens rescued his antibody and enabled him to continue his research. De novo antibody sequencing case study.